Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Benzethonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 2/20 | 1.00 |
| ▸ | CHRM1 known ✓ | P11229 | 2/20 | 1.00 |
| ▸ | CHRM3 known ✓ | P20309 | 2/20 | 1.00 |
| ▸ | ACHE known ✓ | P22303 | 2/20 | 1.00 |
| ▸ | SLC6A2 known ✓ | P23975 | 2/20 | 1.00 |
| ▸ | SLC6A3 known ✓ | Q01959 | 2/20 | 1.00 |
| ▸ | BDKRB2 known ✓ | P30411 | 1/20 | 0.98 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 1.00 |
| ▸ | MEN1 | O00255 | 5/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 5/20 | 1.00 |
| ▸ | TP53 | P04637 | 4/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 4/20 | 1.00 |
| ▸ | HTT | P42858 | 4/20 | 1.00 |
| ▸ | APAF1 | O14727 | 3/20 | 1.00 |
| ▸ | USP2 | O75604 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | RAD52 | P43351 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | TSHR | P16473 | 3/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzethonium SCHEMBL27797280 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2MEN1KMT2ATP53HIF1A | |
| Benzethonium SCHEMBL13278583 | 0.99 | SMN1; SMN2 (0.98) | SMN1; SMN2MEN1KMT2ATP53HIF1A | |
| Benzethonium SCHEMBL10341422 | 0.99 | SMN1; SMN2 (0.98) | SMN1; SMN2MEN1KMT2ATP53HIF1A | |
| Benzethonium SCHEMBL7271857 | 0.99 | SMN1; SMN2 (0.98) | SMN1; SMN2MEN1KMT2ATP53HIF1A | |
| Benzethonium SCHEMBL28210479 | 0.99 | SMN1; SMN2 (0.98) | SMN1; SMN2MEN1KMT2ATP53HIF1A | |
| Benzethonium SCHEMBL976363 | 0.99 | SMN1; SMN2 (0.98) | SMN1; SMN2MEN1KMT2ATP53HIF1A | |
| Benzethonium SCHEMBL122985 | 0.99 | SMN1; SMN2 (1.00) | SMN1; SMN2MEN1KMT2ATP53HIF1A | |
| Benzethonium SCHEMBL976365 | 0.98 | SMN1; SMN2 (0.96) | SMN1; SMN2MEN1KMT2ATP53HIF1A | |
| Benzethonium SCHEMBL4418328 | 0.98 | SMN1; SMN2 (0.98) | SMN1; SMN2MEN1KMT2ATP53HIF1A | |
| Benzethonium SCHEMBL22711570 | 0.98 | SMN1; SMN2 (0.98) | SMN1; SMN2MEN1KMT2ATP53HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 109786 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3836899-B1 | CHEMOTHERAPEUTIC PHARMACEUTICAL SUSPENSION FOR ORAL DOSAGE | ONCOSOL LTD (GB) | 2026-05-27 | — | — | EP | claimed |
| CN-122075673-A | Film-forming hydrogel containing keratin 8 and application thereof in promoting repair of fish body surface injury | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026104286-A1 | PARTICLES COMPRISING A SUPERABSORBENT POLYMER AND A QUATERNARY AMMONIUM COMPOUND | PAUL HARTMANN AG (DE) | 2026-05-21 | — | — | WO | claimed |
| US-20260139383-A1 | CLOSED LOOP COOLING WATER CORROSION INHIBITION EMPLOYING POLYMALEATES AND NON-BORATE BUFFERS | ECOLAB USA INC. (US) | 2026-05-21 | — | — | US | claimed |
| EP-4744685-A1 | PARTICLES COMPRISING A SUPERABSORBENT POLYMER AND A QUATERNARY AMMONIUM COMPOUND | Paul Hartmann AG (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-4743053-A1 | ANTIMICROBIAL SYNERGIES | Symrise AG (DE) | 2026-05-20 | — | — | EP | claimed |
| US-12629340-B2 | Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders | EMPROS PHARMA AB (SE) | 2026-05-19 | — | — | US | claimed |
| CN-117511000-B | Anti-adhesion agent and breeding colony house modifier comprising same | 成都科宏达科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| WO-2026102188-A1 | NANOPARTICLE NAD+ FORMULATIONS AND RELATED METHODS | MOLECULAR WORLD HEALTH, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| US-20260131128-A1 | DISINFECTING CAP WITH PRESSURE SEAL CAPABILITY | BECTON, DICKINSON AND COMPANY (US) | 2026-05-14 | — | — | US | claimed |
| US-4098880-A | CHLORHEXIDINE, ALEXIDINE, BENZETHONIUM CHLORIDE, AND CETYL PYRIDINIUM CHLORIDE | COLGATE-PALMOLIVE COMPANY (US) | 1978-07-04 | — | — | US | claimed |
| US-4080441-A | BIS(O-CARBOXYPHENYL)ESTER OF AN ALIPHATIC DICARBOXYLIC ACID USED AS AN ANTISTAIN AGENT | COLGATE-PALMOLIVE COMPANY (US) | 1978-03-21 | — | — | US | claimed |
| US-4042679-A | BIS-BIGUANIDOHEXANES, QUATERNARY AMMONIUM SALTS, POLYMERIC POLYPHOSPHONIC COMPOUND | COLGATE-PALMOLIVE COMPANY (US) | 1977-08-16 | — | — | US | claimed |
| US-4024871-A | POLYURETHANE | ETHICON, INC. (US) | 1977-05-24 | — | — | US | claimed |
| US-4022911-A | Disinfectant composition comprising a quaternary ammonium compound, a phenol, and formaldehyde | DAMON CORPORATION (US) | 1977-05-10 | — | — | US | claimed |
| US-4006218-A | MICROBIOCIDE | JOHNSON & JOHNSON (US) | 1977-02-01 | — | — | US | claimed |
| US-3987797-A | ANTIMICROBIAL SUTURES | ETHICON, INC. (US) | 1976-10-26 | — | — | US | claimed |
| US-3956480-A | DENTIFRICES, CATIONIC GERMICIDE, ANIONIC POLYMERS | COLGATE-PALMOLIVE COMPANY (US) | 1976-05-11 | — | — | US | claimed |
| US-3950223-A | WATER SOLUBLE AMINO SUGARS, AMINO ACIDS, AND CATIONIC SURFACTANTS | AJINOMOTO CO., INC. (JA) | 1976-04-13 | — | — | US | claimed |
| US-3947570-A | MOUTHWASH, LEMON OIL | COLGATE-PALMOLIVE COMPANY (US) | 1976-03-30 | — | — | US | claimed |